Popular Articles

Sirona Biochem Optimizes Key Test For Diabetes And Obesity Drug Development
Sirona Biochem Corp. (TSX-V: SBM) announced it is now ready to begin testing its novel new compounds to fight diabetes and obesity.

Lobbyists Battle Over Biologic Drug Protections
"As Congress struggles with a massive health care overhaul, several lobbying powerhouses - including the pharmaceutical industry and the nation"s largest advocacy group for retirees - are locked in a contentious fight over the future of biotechnology drugs," USA Today reports in a front page package. "Both sides have spent heavily to sway lawmakers in the debate over how long to keep the expensive drugs exempt from generic competition." The pharmaceutical industry is fighting for 12 years of exclusivity, while President Barack Obama is "pushing for seven years of exclusivity as he looks to trim costs to help pay for his health care plan. ... The pharmaceutical industry counters that a longer period of exclusivity is needed to recover its investments in "biologic drugs," which are made from living organisms and used to treat cancer, multiple sclerosis and other serious diseases."
News of the day
Novel Role Of Gene May Provide Key To Treating Liver And Neurodegenerative Diseases
Scientists at Singapore"s Bioprocessing Technology Institute (BTI) have made a novel discovery about how the gene, "Fas-apoptosis inhibitory molecule" (FAIM), protects both immune and liver cells from apoptosis, or programmed cell death.
Cardiovascular

Smoking, High Blood Pressure And Diabetes In Mid-life Can Lead To Dementia

Middle aged people who smoke, have high blood pressure or diabetes are far more likely to develop dementia in later life, suggests research published ahead of print in the Journal of Neurology, Neurosurgery and Psychiatry. People should consider modifying their lifestyle in mid-life to avoid developing dementia, claims the US research. Dementia is a growing public health problem affecting older people in developed countries. In the US, where the research took place, estimates show that one in six people older than 70 have dementia. Estimates are that the number of people with dementia will grow threefold by 2050, compared with 2000. Previous studies have shown that the presence of cardiovascular risk factors including high blood pressure, diabetes, obesity and smoking increase the risk of developing subsequent dementia, but have often failed to show the relationship. Researchers from the universities of Minnesota, North Carolina and John Hopkins and the University of Mississippi Medical Center studied more than 11,000 people aged 46-70 who were participants in the Atherosclerosis Risk in Communities (ARIC) study in 1990-92. People underwent a physical examination and cognitive testing at that time and they were followed up until 2004 to see how many were hospitalised with dementia. After following their progress, the researchers identified 203 cases of hospitalisation with dementia. Smoking, high blood pressure and diabetes were all strongly associated with dementia in white participants and African-Americans. The results showed that rates of hospitalisation with dementia increased exponentially with age in men and women and in different ethnic backgrounds. Overall, African-Americans had a two and a half times higher rate of hospitalisation than white people and African-American women in particular had the highest rates of all. Current smokers were 70% more likely than those who had never smoked to develop dementia, people with high blood pressure were 60% more likely than those without high blood pressure, and people with diabetes were more than twice as likely than those without diabetes to develop it. No association was found between people who were obese/overweight and dementia in later life. The authors say the results suggest that smoking cessation and prevention or control of high blood pressure and diabetes starting in midlife may have the added benefit of decreasing dementia hospitalisation risk. They conclude: "Our results emphasise the importance of early lifestyle modification and risk factor treatment to prevent dementia." "Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study." J Neurol Neurosurg Psychiatry2009; doi 10.1136/jnnp.2009.176818 Journal Of Neurology, Neurosurgery & Psychiatry


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):